Latest Articles

  • Company Logo for MRK

    Should You Buy Merck Stock After An Upbeat Q2?

    Merck stock   (NYSE: MRK) reported its Q2 results last week, with revenue and earnings comfortably above ours and the street estimates. However, MRK stock has seen a fall of around 4% in a week, with rising concerns over the drug pricing bill. A...


  • Company Logo for MRK

    Will Merck Stock Rise After Its Q2 Results?

    Merck (NYSE: MRK) is scheduled to report its Q2 2022 results on Thursday, July 28. We expect the company to have a robust Q2, with revenue falling in-line and earnings expected to be slightly above the consensus estimates, driven by a continued...


  • Company Logo for MRK

    What’s Happening With Merck Stock?

    Merck stock (NYSE: MRK) has seen a 21% rise YTD, significantly outperforming its peers and the broader markets, with Johnson & Johnson stock up 4%, Pfizer stock down 6%, AbbVie stock up 12%, and the S&P500 index down 19%. There are a coup...


  • Company Logo for MRK

    Is There A Better Pick Over Merck Stock In Animal Health Space?

    We think that Zoetis stock   (NYSE: ZTS) currently is a better pick compared to its peer Merck stock   (NYSE: MRK), despite Zoetis being the more expensive of the two, trading at 9x trailing revenues, compared to just 4x for Merck. This valuati...


  • Company Logo for MRK

    Will Merck Stock Rise After Its Q1 Results?

    Merck (NYSE: MRK) is scheduled to report its Q1 2022 results on Thursday, Apr 28. We expect MRK stock to trend higher in the near term due to a strong Q1, with revenue falling in-line and earnings expected to be comfortably above the consensus ...


  • Company Logo for MRK

    Company Of The Day: Merck

    What? Merck (NYSE:MRK) and AstraZenica’s cancer drug Lynparza has been approved by the U.S. FDA to treat patients with early-stage breast cancer with certain mutations. So What? Merck’s alliance revenue from Lynparza stood at abou...


  • Company Logo for MRK

    What’s Next For Merck Stock After A 6% Fall In A Month?

    The stock price of Merck (NYSE: MRK) has seen a fall of 6% over the last month, while it is down 1% year-to-date. This marks a better performance than the broader markets, with the S&P500 down 6% over the last month but down 10% so far this...


  • Company Logo for MRK

    Will Merck Stock Rise After Its Q4 Results?

    Merck (NYSE: MRK) is scheduled to report its Q4 2021 results on Thursday, Feb 3. We expect MRK stock to trend higher in the near term due to an upbeat Q4, with revenue and earnings expected to be comfortably above the consensus estimates, drive...


  • Company Logo for MRK

    Here’s A Better Pharmaceutical Pick Over Merck Stock

    We think that Bristol Myers Squibb stock (NYSE: BMY) currently is a better pick compared to its industry peer, Merck stock   (NYSE: MRK), given its better growth prospects and comparatively lower valuation, with its stock trading at 3.0x trail...



  • Company Logo for MRK

    Is A Rise Imminent For Merck Stock After An 8% Fall In A Month?

    [Updated: Nov 29, 2021] Merck Covid-19 Pill Update The stock price of Merck (NYSE: MRK) has seen an 8% fall in a month, while it was down nearly 4% on Friday, Nov 26. This can largely be attributed to the company’s recently shared data f...


  • Company Logo for MRK

    What’s Next For Merck Stock After An Upbeat Q3?

    [Updated: Nov 3, 2021] MRK Stock Update Merck (NYSE: MRK) recently reported its Q3 results, which were better than our estimates. The company reported sales of around $13.2 billion (up 20% y-o-y), compared to our estimate of $12.2 billion. Whi...


  • Company Logo for MRK

    Company Of The Day: Merck

    What? Merck (NYSE:MRK) posted a stronger than expected set of Q3 2021 results, with revenue rising by about 20% year-over-year to $13.15 billion and adjusted EPS rising 28% to $1.75. The company also raised its full-year revenue guidance to bet...


  • Company Logo for MRK

    What To Expect From Merck’s Q3?

    Merck (NYSE: MRK) is scheduled to report its Q3 2021 results on Thursday, October 28. We expect the company to likely post revenue and earnings below the consensus estimates, as the spread of Covid-19 delta variant likely impacted the company&#...


  • Company Logo for MRK

    Company Of The Day: Merck

    What? Merck (NY SE: MRK) announced an agreement with Singapore to provide access to its experimental oral Covid-19 antiviral drug, molnupiravir. Australia has already ordered 300,000 courses of the drug, while Thailand, South Korea, Taiwan, a...

Next ▶